Moreover, A20 overexpression has been associated with poor prognosis in ER and progesterone receptor (PR)-negative breast tumor cells; thus, it may be thought of as a new cancer biomarker[6,10,27]. This evidence concerns the gene TNFAIP3 and cancer.